According to @Ultra_Calls, $WGRX is currently undervalued and may replicate a move similar to $MOBX. The stock is linked to a disruption in the $600 billion prescription drug industry, suggesting significant potential for growth. Traders are advised to monitor $WGRX closely along with related small-cap stocks in the pharmaceutical sector.

According to @QCompounding, small-cap stocks are currently demonstrating strong performance, presenting potential opportunities for traders. This trend may indicate a rotation into smaller companies as investors seek higher growth prospects. Traders should monitor this segment closely for potential trading setups.